Molecular Devices last week introduced its IMAP Substrate Finder for tyrosine kinases. Together with the company’s Substrate Finder for serine/threonine kinases, the products provide substrates for the two categories of kinases that make up the human kinome, Molecular Devices said.
GE Healthcare said last week that it has launched SPA (scintillation proximity assays) for GPCR membranes. The assays comprise SPA beads and radioligands from GE Healthcare with GPCR receptor membranes from Euroscreen.
According to the company, the new assays allow researchers working in high-throughput screening to use pre-developed assay protocols for GPCR receptor-ligand binding studies. The protocols offer time savings of as many as 15 days, the company claimed.
SRI Institute said that its Fourth Annual Ion Channels in Drug Discovery and Development conference will be held Oct. 4 and 5 in Philadelphia. The conference will feature keynote speakers Irwin Levitan, professor at the University of Pennsylvania, and Alan Finkel, chief technology officer and senior vice president of Molecular Devices.